{"protocolSection":{"identificationModule":{"nctId":"NCT03618732","orgStudyIdInfo":{"id":"HMRF02133096"},"organization":{"fullName":"Shatin Hospital","class":"OTHER"},"briefTitle":"A Randomized Controlled Trial of Bilateral Movement-based Computer Games Training to Improve Motor Function of Upper Limb and Quality of Life in Sub-acute Stroke Patient","officialTitle":"A Randomized Controlled Trial of Bilateral Movement-based Computer Games Training to Improve Motor Function of Upper Limb and Quality of Life in Sub-acute Stroke Patient"},"statusModule":{"statusVerifiedDate":"2018-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-08-03","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2017-02-01","type":"ACTUAL"},"completionDateStruct":{"date":"2017-02-01","type":"ACTUAL"},"studyFirstSubmitDate":"2017-10-06","studyFirstSubmitQcDate":"2018-08-05","studyFirstPostDateStruct":{"date":"2018-08-07","type":"ACTUAL"},"lastUpdateSubmitDate":"2018-08-05","lastUpdatePostDateStruct":{"date":"2018-08-07","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Lam So Ling, Stefanie","investigatorTitle":"Principal Investigator","investigatorAffiliation":"Shatin Hospital"},"leadSponsor":{"name":"Shatin Hospital","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study aims at investigating whether bilateral movement-based training with computer games could augment motor function of paretic upper limb and improve quality of life in sub-acute stroke patients."},"conditionsModule":{"conditions":["Stroke"],"keywords":["stroke","upper limb","motor control","function","bilateral movement","virtual reality"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"stratified, single-blinded, intervention and controlled study","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":93,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Bilateral movement-based computer training","type":"EXPERIMENTAL","description":"All subjects underwent 16 sessions of assigned treatment (2 times per week; for 8 weeks; 3 hours standardized rehabilitation program per visit) There was 1.5 hours standardized conventional physiotherapy training a 1.5 hours multi-disciplinary program which consisted of standardized occupational therapy, speech therapy and nursing care.\n\nSubjects in Intervention Group will be assigned an additional 30 minutes bilateral movement-based computer games(Able-X) training program of upper limb.","interventionNames":["Other: Bilateral movement-based computer training"]},{"label":"Video-directed conventional training","type":"OTHER","description":"All subjects underwent 16 sessions of assigned treatment (2 times per week; for 8 weeks; 3 hours standardized rehabilitation program per visit) There was 1.5 hours standardized conventional physiotherapy training a 1.5 hours multi-disciplinary program which consisted of standardized occupational therapy, speech therapy and nursing care.","interventionNames":["Other: Video-directed conventional training"]}],"interventions":[{"type":"OTHER","name":"Bilateral movement-based computer training","armGroupLabels":["Bilateral movement-based computer training"]},{"type":"OTHER","name":"Video-directed conventional training","armGroupLabels":["Video-directed conventional training"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Fugl-Meyer Assessment-Upper Extremity Scores (FMA-UE scores) baseline to 4 weeks","description":"The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment. The FMA-UE scores measure motor impairment of upper extremity. The motor domain includes items assessing movement, coordination, and reflex action of the shoulder, elbow, forearm, wrist and hand.","timeFrame":"Change from baseline to 4 weeks"},{"measure":"Fugl-Meyer Assessment-Upper Extremity Scores (FMA-UE scores) baseline to 8 weeks","description":"The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment. The FMA-UE scores measure motor impairment of upper extremity. The motor domain includes items assessing movement, coordination, and reflex action of the shoulder, elbow, forearm, wrist and hand.","timeFrame":"Change from baseline to 8 weeks"},{"measure":"Fugl-Meyer Assessment-Upper Extremity Scores (FMA-UE scores) baseline to followup","description":"The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment. The FMA-UE scores measure motor impairment of upper extremity. The motor domain includes items assessing movement, coordination, and reflex action of the shoulder, elbow, forearm, wrist and hand.","timeFrame":"Change from baseline to 12 weeks (4 weeks after training ended)"}],"secondaryOutcomes":[{"measure":"Action Research Arm Test (ARAT) baseline to 4 weeks","description":"The Action Research Arm Test (ARAT) is an evaluative measure to assess specific changes in limb function among individuals who sustained cortical damage resulting in hemiplegia. It assesses a client's ability to handle objects differing in size, weight and shape and therefore can be considered to be an arm-specific measure of activity limitation.","timeFrame":"Change from baseline to 4 weeks"},{"measure":"Action Research Arm Test (ARAT) baseline to 8 weeks","description":"The Action Research Arm Test (ARAT) is an evaluative measure to assess specific changes in limb function among individuals who sustained cortical damage resulting in hemiplegia. It assesses a client's ability to handle objects differing in size, weight and shape and therefore can be considered to be an arm-specific measure of activity limitation.","timeFrame":"Change from baseline to 8 weeks"},{"measure":"Action Research Arm Test (ARAT) baseline to followup","description":"The Action Research Arm Test (ARAT) is an evaluative measure to assess specific changes in limb function among individuals who sustained cortical damage resulting in hemiplegia. It assesses a client's ability to handle objects differing in size, weight and shape and therefore can be considered to be an arm-specific measure of activity limitation.","timeFrame":"Change from baseline to 12 weeks (4 weeks after training ended)"},{"measure":"Short-Form Health Survey Hong Kong version (HK-SF-36) baseline to 4 weeks","description":"The Short-Form Health Survey (SF-36) is a widely used, generic, patient-report measure created to assess health-related quality of life (HRQOL) in the general population. SF-36 is the most commonly used generic instrument for measuring quality of life.","timeFrame":"Change from baseline to 4 weeks"},{"measure":"Short-Form Health Survey Hong Kong version (HK-SF-36) baseline to 8 weeks","description":"The Short-Form Health Survey (SF-36) is a widely used, generic, patient-report measure created to assess health-related quality of life (HRQOL) in the general population. SF-36 is the most commonly used generic instrument for measuring quality of life.","timeFrame":"Change from baseline to 8 weeks"},{"measure":"Short-Form Health Survey Hong Kong version (HK-SF-36) baseline to followup","description":"The Short-Form Health Survey (SF-36) is a widely used, generic, patient-report measure created to assess health-related quality of life (HRQOL) in the general population. SF-36 is the most commonly used generic instrument for measuring quality of life.","timeFrame":"Change from baseline to 12 weeks (4 weeks after training ended)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age between 45-85\n* Diagnosis of ischaemic brain injury or intracerebral hemorrhage by MRI or computed tomography 1 week to 6 months after the onset of current stroke\n* Scoring \\> 6 of 10 of Abbreviated Mental Test\n* Ability of the paretic hand to hold the game controller (minimal control)\n* Able to give informed consent of the study\n* Can understand instructions given by English or Cantonese\n\nExclusion Criteria:\n\n* Any additional medical, cardiovascular and orthopaedic condition that would hinder the proper assessment and treatment\n* Having cardiac pacemaker\n* Receptive dysphasia\n* Undergoing drug studies or other clinical trials","healthyVolunteers":false,"sex":"ALL","minimumAge":"45 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T6034","name":"Quality of Life","asFound":"Quality of Life","relevance":"HIGH"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}